Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Rheumatoid arthritis (RA) is associated with a 1.5-fold increased risk of cardiovascular disease (CVD).
• Subclinical atherosclerosis often precedes RA diagnosis, contributing to elevated CVD risk.
• Inflammation in RA can lead to myocardial disease, increasing heart failure and mortality risk.

Purpose of the Study:

• To highlight the heightened cardiovascular risk in rheumatoid arthritis patients.
• To emphasize the importance of specific biomarkers for dyslipidemia assessment in RA.
• To outline strategies for mitigating CVD risk in RA management.

Main Methods:

• Review of current literature and risk assessment guidelines for CVD in RA.
• Analysis of the role of lipoproteins and apolipoproteins in RA-associated dyslipidemia.
• Evaluation of inflammatory mechanisms contributing to cardiovascular complications in RA.

Main Results:

• Dyslipidemia in RA is more accurately assessed using lipoproteins and apolipoproteins than traditional cholesterol levels.
• Existing CVD risk factors may underestimate the actual risk in RA patients.
• RA patients exhibit a 2-fold higher risk of heart failure and overall mortality.

Conclusions:

• Aggressive management of RA disease activity and inflammation is essential.
• Intensified treatment of cardiovascular risk factors is recommended for RA patients.
• Early detection and management of atherosclerosis in RA are critical for reducing long-term CVD morbidity and mortality.